165 related articles for article (PubMed ID: 35757013)
21. A study of clinico-pathological parameters and O⁶-methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma.
Singh G; Mallick S; Sharma V; Joshi N; Purkait S; Jha P; Sharma MC; Suri V; Julka PK; Mahapatra AK; Singh M; Kale SS; Sarkar C
Neuropathology; 2012 Oct; 32(5):534-42. PubMed ID: 22380407
[TBL] [Abstract][Full Text] [Related]
22. Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma.
Pierscianek D; Ahmadipour Y; Michel A; Rauschenbach L; Darkwah Oppong M; Deuschl C; Kebir S; Wrede KH; Glas M; Stuschke M; Sure U; Jabbarli R
Clin Neurol Neurosurg; 2021 Jan; 200():106348. PubMed ID: 33158630
[TBL] [Abstract][Full Text] [Related]
23. DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma.
Adeberg S; Knoll M; Koelsche C; Bernhardt D; Schrimpf D; Sahm F; König L; Harrabi SB; Hörner-Rieber J; Verma V; Bewerunge-Hudler M; Unterberg A; Sturm D; Jungk C; Herold-Mende C; Wick W; von Deimling A; Debus J; Rieken S; Abdollahi A
Acta Neuropathol; 2022 Jul; 144(1):129-142. PubMed ID: 35660939
[TBL] [Abstract][Full Text] [Related]
24. Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database.
Shieh LT; Ho CH; Guo HR; Huang CC; Ho YC; Ho SY
Front Neurol; 2021; 12():659921. PubMed ID: 34899553
[No Abstract] [Full Text] [Related]
25. Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome.
Kozak KR; Mahadevan A; Moody JS
Neuro Oncol; 2009 Apr; 11(2):183-91. PubMed ID: 18780813
[TBL] [Abstract][Full Text] [Related]
26. Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity.
Han SJ; Yang I; Tihan T; Prados MD; Parsa AT
J Neurooncol; 2010 Feb; 96(3):313-20. PubMed ID: 19618114
[TBL] [Abstract][Full Text] [Related]
27. GSVD comparison of patient-matched normal and tumor aCGH profiles reveals global copy-number alterations predicting glioblastoma multiforme survival.
Lee CH; Alpert BO; Sankaranarayanan P; Alter O
PLoS One; 2012; 7(1):e30098. PubMed ID: 22291905
[TBL] [Abstract][Full Text] [Related]
28. Gliosarcoma with osteosarcomatous component: A case report and short review illustration.
Chen Y; Zhou S; Zhou X; Dai X; Wang L; Chen P; Zhao S; Shi C; Xiao S; Dong J
Pathol Res Pract; 2022 Apr; 232():153837. PubMed ID: 35278815
[TBL] [Abstract][Full Text] [Related]
29. Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma.
Kong DS; Kim J; Lee IH; Kim ST; Seol HJ; Lee JI; Park WY; Ryu G; Wang Z; Ma'ayan A; Nam DH
Oncotarget; 2016 Mar; 7(10):11526-38. PubMed ID: 26863628
[TBL] [Abstract][Full Text] [Related]
30. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
32. Genetic and pathologic evolution of early secondary gliosarcoma.
Codispoti KE; Mosier S; Ramsey R; Lin MT; Rodriguez FJ
Brain Tumor Pathol; 2014 Jan; 31(1):40-6. PubMed ID: 23324827
[TBL] [Abstract][Full Text] [Related]
33. Gliosarcoma Is Driven by Alterations in PI3K/Akt, RAS/MAPK Pathways and Characterized by Collagen Gene Expression Signature.
Wojtas B; Gielniewski B; Wojnicki K; Maleszewska M; Mondal SS; Nauman P; Grajkowska W; Glass R; Schüller U; Herold-Mende C; Kaminska B
Cancers (Basel); 2019 Feb; 11(3):. PubMed ID: 30818875
[TBL] [Abstract][Full Text] [Related]
34. Glioblastomas with giant cell and sarcomatous features in patients with Turcot syndrome type 1: a clinicopathological study of 3 cases.
Lusis EA; Travers S; Jost SC; Perry A
Neurosurgery; 2010 Sep; 67(3):811-7; discussion 817. PubMed ID: 20657316
[TBL] [Abstract][Full Text] [Related]
35. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
Lehrer S; Rheinstein PH; Rosenzweig KE
Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
[TBL] [Abstract][Full Text] [Related]
36. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
Li M; Long S; Hu J; Wang Z; Geng C; Ou S
Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
[TBL] [Abstract][Full Text] [Related]
37. Integrated Analysis of Multiomics Data Identified Molecular Subtypes and Oxidative Stress-Related Prognostic Biomarkers in Glioblastoma Multiforme.
Ma Y; Xi Z
Oxid Med Cell Longev; 2022; 2022():9993319. PubMed ID: 36193073
[TBL] [Abstract][Full Text] [Related]
38. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
[TBL] [Abstract][Full Text] [Related]
39. Glioblastoma.
Miller CR; Perry A
Arch Pathol Lab Med; 2007 Mar; 131(3):397-406. PubMed ID: 17516742
[TBL] [Abstract][Full Text] [Related]
40. Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma.
Buchwald ZS; Tian S; Rossi M; Smith GH; Switchenko J; Hauenstein JE; Moreno CS; Press RH; Prabhu RS; Zhong J; Saxe DF; Neill SG; Olson JJ; Crocker IR; Curran WJ; Shu HG
Sci Rep; 2020 Apr; 10(1):7355. PubMed ID: 32355162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
